Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Avgust Garin"'
Autor:
Nikita A. Savelov, Anatoly Bulanov, Dmitry A. Nosov, Avgust Garin, Maria S. Sayapina, Apollon Karseladze, S. A. Tjulandin, Alexey Tryakin
Publikováno v:
Rare Tumors, Vol 8, Iss 2 (2016)
Rare Tumors
Rare Tumors
Nuclear protein of the testis (NUT) midline carcinomas are rare aggressive carcinomas characterized by chromosomal rearrangements that involve the gene encoding the NUT. This article reviews the clinicopathologic features and the differential diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939288b82f533aaeba9b409c67927e4c
https://doi.org/10.4081/rt.2016.6241
https://doi.org/10.4081/rt.2016.6241
Autor:
Pavel Vodvarka, Alan Swaisland, Denis Soulières, Alison Armour, Fred R. Hirsch, Lisa Licitra, J.Simon W Stewart, Chonlakiet Khorprasert, Georgina Speake, Marileila Varella-Garcia, Everett E. Vokes, Carla M.L. van Herpen, Avgust Garin, Ezra E.W. Cohen, Laura Hargreaves, Serban Ghiorghiu, Danny Rischin
Publikováno v:
Journal of Clinical Oncology, 27, 1864-71
Journal of Clinical Oncology, 27, 11, pp. 1864-71
Journal of Clinical Oncology, 27, 11, pp. 1864-71
Purpose To compare survival in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) treated with gefitinib 250 or 500 mg/day or standard methotrexate. Patients and Methods Four hundred eighty-six patients with re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf1498bce43404ba22fcce506a0aef7
https://pubmed.ncbi.nlm.nih.gov/19289630
https://pubmed.ncbi.nlm.nih.gov/19289630
Autor:
Leonard, Reyno, Lesley, Seymour, Dongsheng, Tu, Susan, Dent, Karen, Gelmon, Barbara, Walley, Anna, Pluzanska, Vera, Gorbunova, Avgust, Garin, Jacek, Jassem, Tadeusz, Pienkowski, Janet, Dancey, Laura, Pearce, Mary, MacNeil, Susan, Marlin, David, Lebwohl, Maurizio, Voi, Kathleen, Pritchard
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(2)
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE; tesmilifene) is a novel agent that augments chemotherapy cytotoxicity in vitro and in vivo. A phase II trial combining DPPE and doxorubicin (DOX) in metastatic breast carcinoma showed increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::585d28949a078c94131d5d6084802d87
https://pubmed.ncbi.nlm.nih.gov/14722035
https://pubmed.ncbi.nlm.nih.gov/14722035
Autor:
Walter Bordogna, Limas Kupčinskas, Irina Davidenko, C. Hillenbach, Sufiya Safina, Alberto Fittipaldo, Barbara Klughammer, Giovanni Gerardo Cardellino, Michel Ducreux, Avgust Garin, David Propper, Minesh Jain, John Bridgewater
Publikováno v:
Annals of Oncology. 23:iv7
Introduction Erlotinib, an epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor, is approved in combination with gemcitabine for advanced pancreatic cancer. As the use of biomarkers to guide treatment decisions for targeted therapies is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0d845937937e8591c0c2dbb4b42f252
https://doi.org/10.1016/s0923-7534(19)66472-0
https://doi.org/10.1016/s0923-7534(19)66472-0